Press Releases
Press Releases
Biocon Biologics Partners with Adagio Therapeutics to Advance Antibody for the Prevention and Treatment of COVID-19
Biocon Biologics Ltd., a fully integrated biosimilars company and a subsidiary of Biocon Ltd. announced that U.S. based Adagio Therapeutics has granted an exclusive license to Biocon Biologics to manufacture and commercialize an antibody treatment based on ADG20 for...
Press Releases
Catalent Launches New OptiDose Design Solution to Help Create Differentiated Treatments that are Successful for Innovators, Patients and Health Care Professionals
Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, announced the launch of its new OptiDose® Design Solution, at the Controlled Release Society (CRS)...
Press Releases
ISR signs agreement with Singapore Resources Dev regarding investment in subsidiaries for the development of inhaled COVID-19 vaccine
ISR Immune System Regulation Holding AB (publ), which develops inhalation vaccine against Covid-19, today announced that it has signed an investment agreement with Singapore Resources Development PTE. Ltd. Singapore Resources Development PTE. Ltd. invests in various stages and after...
Press Releases
Moderna To Supply Addl 50 Mln Doses Of COVID-19 Vaccine And Booster Vaccine To Japan
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that the Ministry of Health, Labour and Welfare of Japan (MHLW) and Takeda Pharmaceutical Company Limited have agreed to purchase and distribute an additional 50 million...
Press Releases
Japan becomes first country to approve Roche’s Ronapreve Covid treatment
Roche announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved Ronapreve™(casirivimab and imdevimab), for the treatment of patients with mild to moderate COVID-19 via intravenous infusion. The antibody combination was granted a Special Approval Pathway under...
Press Releases
GSK unveils plan for one of Europes largest life science campuses in Stevenage
GSK has announced that it has formally started the process of seeking a development partner to transform land within the company’s existing 92-acre Research & Development site in Stevenage into one of Europe’s largest ‘clusters’ for biotechnology and other...
Drug Research
Kineta and Samsung Biologics Announce Development and Manufacturing Agreement for Anti-VISTA Antibody Immunotherapy
Samsung Biologics, one of the world’s leading contract development and manufacturing organization (CDMO), signed a strategic partnership agreement with Kineta, Inc., a clinical-stage biotech company developing novel immunotherapies in oncology. Samsung Biologics will provide end-to-end CDMO service from cell...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.